Internal Medicine, Pulmonary Disease · Wichita, KS
NPI
1548261415
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
6
Hospital affiliations
3009 N. Cypress
Wichita, KS, 67226
Phone (316) 440-1010
Groups this clinician bills Medicare through
Medicare paid, 2024
$351K
4,190 services
Medicare patients, 2024
1,450
Average age 74
Drug cost, 2024
$2.0M
3,045 prescriptions
Company payments, 2025
$1,031
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maged M El-Zein was code 99214 (office e&m - established), 1,590 times for 1,067 patients. In total Maged M El-Zein billed 4,190 services in 46 codes, and Medicare paid $351K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,590 | 1,067 | $84.18 | $134K |
| 99233 Hospital E&M - Subsequent | Facility | 763 | 227 | $84.20 | $64K |
| 99204 Office E&M - New | Office | 282 | 282 | $106.55 | $30K |
| 94060 Pulmonary Function Testing | Office | 215 | 210 | $26.52 | $5,703 |
| 94729 Pulmonary Function Testing | Office | 199 | 191 | $37.21 | $7,404 |
| 94726 Pulmonary Function Testing | Office | 176 | 169 | $37.71 | $6,637 |
| 99232 Hospital E&M - Subsequent | Facility | 151 | 60 | $56.71 | $8,563 |
| 71046 X-ray - Chest | Office | 115 | 106 | $22.94 | $2,638 |
| 99215 Office E&M - Established | Office | 108 | 87 | $127.82 | $14K |
| 94762 Pulmonary | Office | 107 | 87 | $16.52 | $1,767 |
| 95806 Sleep Study | Office | 97 | 94 | $64.73 | $6,279 |
| 99291 Critical Care E&M | Facility | 83 | 38 | $153.92 | $13K |
| 95811 Sleep Study | Office | 56 | 55 | $437.74 | $25K |
| 95810 Sleep Study | Office | 38 | 37 | $443.98 | $17K |
| 94727 Pulmonary Function Testing | Office | 26 | 26 | $27.06 | $703 |
By year: 2022 $333K for 4,236 services; 2023 $366K for 4,561 services; 2024 $351K for 4,190 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87426 Immunoassay | 26 | 26 | $35.28 | $917 |
Medicare prescription drug claims, 2024
In 2024, the drug Maged M El-Zein prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 524 prescriptions and refills. In total Maged M El-Zein wrote 3,045 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 524 | 613 | 85 | $391K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 334 | 390 | 131 | $7,718 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 259 | 273 | 43 | $169K |
| Breo Ellipta Fluticasone/Vilanterol | 218 | 240 | 35 | $95K |
| Azithromycin Generic | 110 | 119 | 21 | $633 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 108 | 122 | 17 | $56K |
| Prednisone Generic | 101 | 125 | 48 | $214 |
| Montelukast Sodium Generic | 98 | 196 | 19 | $839 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 93 | 106 | 25 | $15K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 74 | 100 | 17 | $8,750 |
| Advair Hfa Fluticasone Propion/Salmeterol | 72 | 75 | Under 11 | $22K |
| Spiriva Respimat Tiotropium Bromide | 66 | 78 | 11 | $41K |
| Symbicort Budesonide/Formoterol Fumarate | 61 | 65 | 20 | $15K |
| Arnuity Ellipta Fluticasone Furoate | 56 | 69 | Under 11 | $15K |
| Incruse Ellipta Umeclidinium Bromide | 55 | 73 | 11 | $25K |
Brand drugs: 2,053 claims; generic drugs: 992 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maged M El-Zein $1,031 ($1,031 in general payments such as food, travel and fees) from 16 companies. The largest payer was Genzyme Corporation with $244.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 10 | $244 |
| GlaxoSmithKline, LLC. GSK | 14 | $225 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $176 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $125 |
| Grifols USA, LLC | 1 | $33.33 |
| Lilly USA, LLC LLY | 2 | $33.2 |
| Electromed, Inc. ELMD | 2 | $29.89 |
| Genentech USA, Inc. ROG.SW | 1 | $28.22 |
| Merck Sharp & Dohme LLC MRK | 1 | $21.26 |
| Amgen Inc. AMGN | 1 | $17.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.